Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q3 2016 · 10-Q
Revenue$18.67K$18.67K— vs Q3 2015 Net Income-$1.12M-$1.12MN/M vs Q3 2015 EPS Diluted$0.00$0.00— vs Q3 2015 Operating Income-$1,089,129N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$221,003N/M Margins · derivedOperating margin-5832.6%
Net margin-6021.9%
ended Sep 30, 2016 · filed Nov 14, 2016 · 45 d after period end